WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACRS

Based on 2 analysts offering 12 month price targets for Aclaris Therapeutics Inc.
Min Forecast
$1.00-18.03%
Avg Forecast
$5.00+309.84%
Max Forecast
$9.00+637.7%

Should I buy or sell ACRS stock?

Based on 2 analysts offering ratings for Aclaris Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACRS stock forecasts and price targets.

ACRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-29
lockedlocked$00.00+00.00%2023-12-18

1 of 1

Forecast return on equity

Is ACRS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is ACRS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ACRS revenue forecast

What is ACRS's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$7.6M-75.83%
Avg 2 year Forecast
$9.0M-71.19%
Avg 3 year Forecast
$10.9M-65.16%
ACRS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACRS revenue growth forecast

How is ACRS forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
-29.88%
Industry
6.32%
Market
10.1%
ACRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACRS vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
ACRS$1.22$5.00+309.84%Buy
BNR$0.86N/AN/A
PRPH$4.90$11.00+124.49%Buy
FONR$16.20N/AN/A
PSNL$1.26$3.50+177.78%Buy

Aclaris Therapeutics Stock Forecast FAQ

Is Aclaris Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ACRS) stock is to Buy ACRS stock.

Out of 2 analysts, 0 (0%) are recommending ACRS as a Strong Buy, 1 (50%) are recommending ACRS as a Buy, 1 (50%) are recommending ACRS as a Hold, 0 (0%) are recommending ACRS as a Sell, and 0 (0%) are recommending ACRS as a Strong Sell.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.

What is ACRS's revenue growth forecast for 2024-2026?

(NASDAQ: ACRS) Aclaris Therapeutics's forecast annual revenue growth rate of -29.88% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Aclaris Therapeutics's revenue in 2024 is $31,249,000.On average, 6 Wall Street analysts forecast ACRS's revenue for 2024 to be $535,767,767, with the lowest ACRS revenue forecast at $160,290,595, and the highest ACRS revenue forecast at $1,517,795,899. On average, 5 Wall Street analysts forecast ACRS's revenue for 2025 to be $638,609,078, with the lowest ACRS revenue forecast at $160,290,595, and the highest ACRS revenue forecast at $1,666,738,487.

In 2026, ACRS is forecast to generate $772,090,007 in revenue, with the lowest revenue forecast at $160,290,595 and the highest revenue forecast at $1,836,958,588.

What is ACRS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ACRS) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of N/A.

What is ACRS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ACRS price target, the average ACRS price target is $5.00, with the highest ACRS stock price forecast at $9.00 and the lowest ACRS stock price forecast at $1.00.

On average, Wall Street analysts predict that Aclaris Therapeutics's share price could reach $5.00 by Dec 29, 2024. The average Aclaris Therapeutics stock price prediction forecasts a potential upside of 309.84% from the current ACRS share price of $1.22.

What is ACRS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ACRS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.